| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |